Entity Details

Primary name COG2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ14746
EntryNameCOG2_HUMAN
FullNameConserved oligomeric Golgi complex subunit 2
TaxID9606
Evidenceevidence at protein level
Length738
SequenceStatuscomplete
DateCreated1997-11-01
DateModified2021-06-02

Ontological Relatives

GenesCOG2

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0005795 Golgi stack
GO:0005829 cytosol
GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport
GO:0006891 intra-Golgi vesicle-mediated transport
GO:0007030 Golgi organization
GO:0015031 protein transport
GO:0017119 Golgi transport complex
GO:0032588 trans-Golgi network membrane
GO:0044877 protein-containing complex binding

Subcellular Location

Show/Hide Table
Subcellular Location
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR009316 COG complex component, COG2FamilyFamily
IPR024602 Conserved oligomeric Golgi complex, subunit 2, N-terminalDomainDomain
IPR024603 COG complex component, COG2, C-terminalDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617395 OMIMCongenital disorder of glycosylation 2Q (CDG2Q)A form of congenital disorder of glycosylation, a genetically heterogeneous group of autosomal recessive, multisystem disorders caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The transmission pattern of CDG2Q is consistent with autosomal recessive inheritance. The disease is caused by variants affecting the gene represented in this entry.